{"doi":"10.1101/2025.05.28.656643","title":"PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4","abstract":"ABSTRACT PAMD-Ch17 is a polymer composed of the CXCR4 inhibitor AMD3100/Plerixafor with a cholesterol modification. In previous work, we showed that PAMD-Ch17, but not AMD3100, induces cell death and differentiation in mouse Acute Myeloid Leukemia cells. To investigate the mechanism of PAMD-Ch17’s novel anti-leukemic effects, we tested PAMD-Ch17 against a panel of human leukemia cell lines and found that PAMD-Ch17 is effective against a variety of acute leukemias, with T-ALL cell lines being highly sensitive. Surprisingly, CXCR4 knock out T-ALL cells were equally sensitive to PAMD-Ch17. Using a fluorescently tagged PAMD-Ch17, we found that the drug colocalized to the mitochondria. We also found that PAMD-Ch17 induced changes in expression of genes related to mitochondrial function, increased levels of mitochondrial superoxide, and decreased mitochondrial membrane potential. Using seahorse assays, we found that PAMD-Ch17 decreased baseline oxygen consumption, ATP production, and proton leakage. PAMD-Ch17 also decreased baseline extracellular acidification rate, indicating a decrease in overall metabolism. In mouse primary T-ALL but not healthy bone marrow cells, PAMD-Ch17 induced both mitochondrial superoxide and cell death. Using human bone marrow organoids, we found that PAMD-Ch17 induced mitochondrial superoxide and cell death in human primary T-ALL cells, but not in healthy stromal and hematopoietic cells. Collectively, our results indicate that PAMD-Ch17 has anti-leukemic effects against T-ALL cells but not healthy cells, likely mediated through a CXCR4 independent, mitochondrial based mechanism. These findings support further development of PAMDs as potential therapeutics for patients with T-ALL. KEY POINTS PAMD-Ch17, a polymeric drug based on AMD3100/Plerixafor, has novel anti-leukemic activities against T-ALL that are independent of CXCR4 inhibition. PAMD-Ch17 induces increased mitochondrial superoxide and cell death in primary ALL cells, but not healthy bone marrow cells.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2025,"id":567312,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9582,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1470614,"name":"Arjun Dhir","orcid":null,"position":1,"is_corresponding":false},{"id":683210,"name":"Chinmay M. Jogdeo","orcid":"0000-0003-0018-1684","position":2,"is_corresponding":false},{"id":1463429,"name":"Sipra Panda","orcid":"0000-0001-7145-6273","position":3,"is_corresponding":false},{"id":890374,"name":"Ekta Kapoor","orcid":"0000-0001-9023-8941","position":4,"is_corresponding":false},{"id":524099,"name":"Siyuan Tang","orcid":"0000-0002-4905-8428","position":5,"is_corresponding":false},{"id":1471721,"name":"Victor Rivero","orcid":null,"position":6,"is_corresponding":false},{"id":1471722,"name":"Erin M. McIntyre","orcid":null,"position":7,"is_corresponding":false},{"id":312106,"name":"Donald W. Coulter","orcid":"0000-0002-7829-0971","position":8,"is_corresponding":false},{"id":1231060,"name":"Peng Xiao","orcid":"0000-0001-5187-0119","position":9,"is_corresponding":false},{"id":333402,"name":"Adrian R. Black","orcid":"0000-0003-1560-6921","position":10,"is_corresponding":false},{"id":999294,"name":"Kyle J. Hewitt","orcid":"0000-0003-1946-625X","position":11,"is_corresponding":false},{"id":259686,"name":"Samantha Swenson","orcid":"0000-0002-5650-3841","position":12,"is_corresponding":false},{"id":382999,"name":"Svetlana Romanova","orcid":"0000-0001-7506-4699","position":13,"is_corresponding":false},{"id":678518,"name":"David Oupický","orcid":"0000-0003-4710-861X","position":14,"is_corresponding":false},{"id":503528,"name":"R. Katherine Hyde","orcid":"0000-0003-2808-1749","position":15,"is_corresponding":false},{"id":1338844,"name":"Calvin Lam","orcid":"0000-0003-2768-4230","position":0,"is_corresponding":true}],"reference_count":63,"raw_metadata":null,"created_at":"2026-07-19T02:56:44.340853Z","pmid":"40501752","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}